Walleye Capital
SCPH

Walleye Capital’s scPharmaceuticals SCPH Stock Holding History

Walleye Capital’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,284
Closed -$43K – 5130
2025
Q2 		$43K Buy
+11,284
New +$35K ﹤0.01% 4083
2024
Q4 		– Sell
-475,555
Closed -$2.17M – 5523
2024
Q3 		$2.17M Buy
475,555
+101,148
+27% +$489K 0.02% 1867
2024
Q2 		$1.63M Sell
374,407
-181,779
-33% -$799K 0.02% 2312
2024
Q1 		$2.79M Sell
556,186
-282,694
-34% -$1.58M 0.03% 1745
2023
Q4 		$5.26M Buy
838,880
+412,360
+97% +$2.36M 0.07% 1077
2023
Q3 		$3.04M Sell
426,520
-133,140
-24% -$1.05M 0.04% 1401
2023
Q2 		$5.7M Buy
+559,660
New +$5.84M 0.1% 654
2020
Q3 		– Sell
-20,943
Closed -$154K – 956
2020
Q2 		$154K Buy
+20,943
New +$184K 0.03% 467

Other funds holding SCPH

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.43B AUM 42.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $18.6B AUM 29.12% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $168B AUM 27.2% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return